BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22153886)

  • 1. Variation, precision and validity of 1-year survival estimates for lung, breast, colon and prostate cancer in South East England primary care trusts.
    Lake J; Mak V; Møller H; Davies EA
    Public Health; 2012 Jan; 126(1):57-63. PubMed ID: 22153886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why did treatment rates for colorectal cancer in south east England fall between 1982 and 1988? The effect of case ascertainment and registration bias.
    Pollock AM; Benster R; Vickers N
    J Public Health Med; 1995 Dec; 17(4):419-28. PubMed ID: 8639341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer survival analysis in Hamburg 1995-2003: assessing the data quality within a population-based registry.
    Nennecke AL; Hentschel S; Reintjes R
    Acta Oncol; 2009; 48(1):34-43. PubMed ID: 18607873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
    Engholm G; Gislum M; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Would compliance with cancer care standards improve survival for breast, colorectal and lung cancers?
    McCarthy M; Datta P; Khachatryan A; Coleman MP; Rachet B
    J Epidemiol Community Health; 2008 Jul; 62(7):650-4. PubMed ID: 18559449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using funnel plots to explore variation in cancer mortality across primary care trusts in South-East England.
    Davies E; Mak V; Ferguson J; Conaty S; Møller H
    J Public Health (Oxf); 2008 Sep; 30(3):305-12. PubMed ID: 18567570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deriving valid population-based cancer survival estimates in the presence of nonnegligible proportions of cancers notified by death certificates only.
    Brenner H; Holleczek B
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2480-6. PubMed ID: 21960691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year relative survival from prostate, breast, colorectal and lung cancer.
    Ellison LF; Gibbons L;
    Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of population-based cancer survival estimates by trace back of death certificate notifications: an empirical illustration.
    Holleczek B; Brenner H
    Eur J Cancer; 2012 Apr; 48(6):797-804. PubMed ID: 21703847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reported cancer spending in relation to population characteristics, disease burden and service activity for primary care trusts in South East England.
    Okello C; Møller H; Davies EA
    J Public Health (Oxf); 2011 Sep; 33(3):445-52. PubMed ID: 21051461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leading cancers--changes in five-year relative survival.
    Ellison LF; Gibbons L
    Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates.
    Robinson D; Sankila R; Hakulinen T; Møller H
    Eur J Cancer; 2007 Mar; 43(5):909-13. PubMed ID: 17300929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
    Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.
    Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J;
    Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer survival in Kentucky and health insurance coverage.
    McDavid K; Tucker TC; Sloggett A; Coleman MP
    Arch Intern Med; 2003 Oct; 163(18):2135-44. PubMed ID: 14557210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Travel times to health care and survival from cancers in Northern England.
    Jones AP; Haynes R; Sauerzapf V; Crawford SM; Zhao H; Forman D
    Eur J Cancer; 2008 Jan; 44(2):269-74. PubMed ID: 17888651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage at diagnosis and early mortality from cancer in England.
    McPhail S; Johnson S; Greenberg D; Peake M; Rous B
    Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study.
    Dregan A; Moller H; Murray-Thomas T; Gulliford MC
    Cancer Epidemiol; 2012 Oct; 36(5):425-9. PubMed ID: 22727737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 20-year retrospective study of tonsil cancer incidence and survival trends in South East England: 1987-2006.
    Olaleye O; Moorthy R; Lyne O; Black M; Mitchell D; Wiseberg J
    Clin Otolaryngol; 2011 Aug; 36(4):325-35. PubMed ID: 21696555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.